サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1794535

オフィスベースのラボの世界市場

Office-based Labs

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
オフィスベースのラボの世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オフィスベースのラボの世界市場は2030年までに346億米ドルに達する見込み

2024年に242億米ドルと推定されるオフィスベースのラボの世界市場は、2024年から2030年にかけてCAGR 6.1%で成長し、2030年には346億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである単一専門セットアップモデルは、CAGR 4.9%を記録し、分析期間終了までに194億米ドルに達すると予測されます。マルチスペシャリティセットアップモデルセグメントの成長率は、分析期間中CAGR 8.2%と推定されます。

米国市場は推定66億米ドル、中国はCAGR9.4%で成長予測

米国のオフィスベースのラボ市場は、2024年に66億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに70億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1%と5.9%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界のオフィスベースのラボ市場- 主要動向と促進要因のまとめ

なぜオフィスベースのラボは好ましいヘルスケア提供環境として台頭しているのか？

オフィスベースのラボ（OBL）は、様々な低侵襲診断・治療処置において、病院での治療に代わる効果的な選択肢と見なされるようになってきています。これらの施設は、多くの場合、インターベンショナル・カーディオロジスト、血管外科医、放射線科医などの専門家によって運営されており、医師自身の診療所内で治療を行うことができます。このモデルは、スケジュールの柔軟性を向上させるだけでなく、病院のインフラへの依存を減らし、コスト効率と患者の利便性の両方を向上させる。

多くの医師にとって、OBLモデルは臨床ワークフローや患者との関係をよりよくコントロールできます。血管形成術、ステント留置術、静脈焼灼術など、かつては病院に限られていた手技も、質や安全性を損なうことなく、外来で安全に実施できるようになりました。患者は、待ち時間の短縮、院内感染への曝露の減少、慣れ親しんだ環境での個別化されたケアなどの恩恵を受けています。分散化されたヘルスケア・サービスへの需要が高まる中、OBLは高水準のケアを維持しながら、アクセスのギャップを埋めるのに役立っています。

OBLの成長を支える技術革新と経営革新とは？

医療技術の革新は、OBLで実施できる手技の範囲を大幅に拡大しています。ポータブル・イメージング、カテーテル・ベース・デバイス、レーザー・システムなどの進歩により、小規模で非病院的な環境での正確な介入が可能になりました。これらのテクノロジーはインフラをあまり必要としないため、セットアップコストを下げ、外来安全基準の遵守を簡素化します。統合診断プラットフォーム、デジタル・ワークフロー・ツール、遠隔テクニカル・サポートは、業務効率と臨床実績をさらに向上させる。

運営モデルも成熟し、OBLの設立と規模拡大が容易になりました。多くの医療機関は現在、ラボの建設、機器の調達、スタッフのトレーニングなどをターンキーサービスのベンダーと提携して行っています。加えて、個々のニーズに合わせた診療報酬のサポート、規制に関するコンサルティング、サプライチェーンの調整などが、病院での診療から独立した外来診療への移行を進める医師を支援しています。このようなエコシステムにより、従来の参入障壁の多くが取り除かれ、専門分野や地域を超えたOBLモデルの広範な導入が可能となっています。

どのような市場・政策動向がオフィスベースのラボのリーチを広げているか？

ヘルスケアシステムは、費用対効果の高いケア提供を積極的に推進しており、OBLはより低い運営コストで質の高いサービスを提供することで、この目標に合致しています。現在、いくつかの地域で実施されている診療報酬改革では、OBLで行われる処置が病院で行われる処置と同様の報酬を受けることができるよう、部位中立性が支持されています。このことは、医療提供者にとって、適切な手技を、諸経費が低く、スケジューリングがより合理的な外来ラボにシフトさせる有力なインセンティブとなっています。

患者の嗜好もこのシフトに影響を与えています。現在、多くの患者が、回復に要する時間が短く、日常生活への支障が最小限の、便利なケアを求めています。OBLは、病院システムの複雑さや非人間性を回避した環境で、即日処置を提供することで、このニーズに応えています。予防医療の成長、慢性疾患罹患率の上昇、十分なサービスを受けていない地域への拡大が、OBL導入のさらなる推進力となっています。OBLモデルに対する認識と信頼が高まるにつれ、これらのラボは専門診療所の成長戦略の標準的な一部となりつつあります。

オフィスベースのラボ市場の成長は、いくつかの要因によってもたらされます。

価値観に基づく医療へのシフトにより、医師は臨床の自律性と費用対効果を両立させるモデルを求めており、OBLは安全性を損なうことなく外来処置を可能にすることでこのニーズに合致しています。技術革新、特に小型のインターベンショナルツールや画像診断システムの進歩は、オフィスベースの環境で安全に実施できる手技の範囲を広げています。低コストの医療環境を支持する償還政策の進化は、支払者と医療提供者の双方にとってOBLの経済的な実行可能性を強化しています。さらに、患者中心のケア、回復期間の短縮、病院への依存度の低減に対する要求の高まりは、外来ソリューションへの嗜好を高めています。ラボのセットアップ、コンプライアンス、スタッフ配置などのサポート体制が改善され続けていることから、オフィスベースのラボは都市部と地方市場の両方において、専門医療提供の中核的な要素になると予想されます。

セグメント

セットアップ・モデル（単一専門分野セットアップ・モデル、複数専門分野セットアップ・モデル、ハイブリッド・セットアップ・モデル）;サービス（末梢血管インターベンション、インターベンショナル・ラジオロジー、血管内治療、心臓血管、その他サービス）

調査対象企業の例

  • Abbott Laboratories
  • ACM Global Laboratories
  • ARUP Laboratories
  • BioReference Laboratories
  • Cleveland Clinic Laboratories
  • DaVita Labs
  • Envision Healthcare
  • Fresenius Medical Care
  • GE Healthcare
  • HCA Healthcare
  • LabCorp（Laboratory Corporation of America）
  • Mayo Clinic Laboratories
  • Mednax（Mednax Lab Services）
  • PPD（Lab Services）
  • Philips（Diagnostic & Point-of-Care Solutions）
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific
  • Trinity Biotech

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37537

Global Office-based Labs Market to Reach US$34.6 Billion by 2030

The global market for Office-based Labs estimated at US$24.2 Billion in the year 2024, is expected to reach US$34.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Single Specialty Set-Up Model, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.4 Billion by the end of the analysis period. Growth in the Multi-Specialty Set-Up Model segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.6 Billion While China is Forecast to Grow at 9.4% CAGR

The Office-based Labs market in the U.S. is estimated at US$6.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Office-Based Labs Market - Key Trends & Drivers Summarized

Why Are Office-Based Labs Emerging as a Preferred Healthcare Delivery Setting?

Office-based labs (OBLs) are increasingly seen as an effective alternative to hospital-based care for a variety of minimally invasive diagnostic and therapeutic procedures. These facilities, often operated by specialists such as interventional cardiologists, vascular surgeons, and radiologists, allow treatments to be performed within the physician’s own practice. This model not only improves scheduling flexibility but also reduces reliance on hospital infrastructure, enhancing both cost-efficiency and patient convenience.

For many physicians, the OBL model offers better control over clinical workflows and patient relationships. Procedures that were once limited to hospitals, such as angioplasties, stent placements, and venous ablations, can now be safely performed in outpatient settings without compromising quality or safety. Patients benefit from shorter wait times, reduced exposure to hospital-acquired infections, and personalized care within a familiar environment. As demand grows for decentralized healthcare services, OBLs are helping bridge accessibility gaps while maintaining a high standard of care.

How Are Technological and Operational Innovations Supporting the Growth of OBLs?

Innovations in medical technology are significantly expanding the scope of procedures that can be performed in OBLs. Advances in portable imaging, catheter-based devices, and laser systems have enabled precise interventions in smaller, non-hospital settings. These technologies require less infrastructure, which lowers setup costs and simplifies compliance with outpatient safety standards. Integrated diagnostic platforms, digital workflow tools, and remote technical support further enhance operational efficiency and clinical performance.

Operational models have also matured, making OBLs easier to establish and scale. Many providers now partner with turnkey service vendors for lab construction, equipment procurement, and staff training. Additionally, customized reimbursement support, regulatory consulting, and supply chain coordination are helping physicians navigate the transition from hospital-based practice to independent outpatient care. This ecosystem of support is removing many of the traditional barriers to entry, enabling broader adoption of the OBL model across specialties and geographies.

What Market and Policy Trends Are Expanding the Reach of Office-Based Labs?

Healthcare systems are actively promoting cost-effective care delivery, and OBLs align with this goal by offering high-quality services at lower operational costs. Reimbursement reforms in several regions now support site-of-service neutrality, allowing procedures performed in OBLs to receive similar compensation as those conducted in hospitals. This creates a compelling incentive for providers to shift suitable procedures to outpatient labs, where overheads are lower and scheduling is more streamlined.

Patient preferences are also influencing this shift. Many individuals now seek convenient care experiences with shorter recovery times and minimal disruption to daily routines. OBLs meet this need by offering same-day procedures in a setting that avoids the complexity and impersonality of hospital systems. Growth in preventive care, rising chronic disease incidence, and expansion into underserved areas are further driving adoption. As awareness and trust in the OBL model increase, these labs are becoming a standard part of specialty practice growth strategies.

Growth in the office-based labs market is driven by several factors.

The shift toward value-based care is prompting physicians to seek models that combine clinical autonomy with cost-effectiveness, and OBLs fit this need by enabling outpatient procedures without compromising safety. Technological innovations, particularly in compact interventional tools and imaging systems, are broadening the procedural scope that can be safely delivered in office-based settings. Evolving reimbursement policies that favor lower-cost care environments are reinforcing the financial viability of OBLs for both payers and providers. Additionally, the rising demand for patient-centered care, shorter recovery timelines, and reduced hospital dependency is increasing preference for outpatient solutions. As support systems for lab setup, compliance, and staffing continue to improve, office-based labs are expected to become a core component of specialty care delivery in both urban and regional markets.

SCOPE OF STUDY:

The report analyzes the Office-based Labs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Set-Up Model (Single Specialty Set-Up Model, Multi-Specialty Set-Up Model, Hybrid Set-Up Model); Service (Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular, Other Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • ACM Global Laboratories
  • ARUP Laboratories
  • BioReference Laboratories
  • Cleveland Clinic Laboratories
  • DaVita Labs
  • Envision Healthcare
  • Fresenius Medical Care
  • GE Healthcare
  • HCA Healthcare
  • LabCorp (Laboratory Corporation of America)
  • Mayo Clinic Laboratories
  • Mednax (Mednax Lab Services)
  • PPD (Lab Services)
  • Philips (Diagnostic & Point-of-Care Solutions)
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific
  • Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Office-based Labs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Decentralized, Patient-Centric Care Models Drives Growth of Office-Based Labs (OBLs)
    • Expansion of Ambulatory and Outpatient Services Spurs Need for On-Site Diagnostic and Minor Procedure Capabilities
    • Increased Efficiency and Shorter Wait Times Enhance Adoption of OBLs Across Specialties Like Cardiology, Endoscopy, and Urology
    • Shift Toward Value-Based Care Models Throws Spotlight on Cost-Effective and High-Quality In-Office Testing and Treatment
    • Advancements in Portable Diagnostic Equipment and Minimally Invasive Tools Support Broader Lab Functionality
    • Growing Physician Ownership and Autonomy Encourages Investment in Dedicated Office-Based Lab Infrastructure
    • Favorable Reimbursement Policies and CPT Code Expansion Enhance Financial Viability of OBLs
    • Rising Patient Preference for Convenient, Localized Care Boosts Utilization of In-Office Lab Services
    • Integration of Electronic Health Records and Cloud-Based Imaging Systems Improves Workflow and Patient Management
    • Rising Demand for Minimally Invasive Outpatient Procedures Spurs Growth in Office-Based Lab (OBL) Installations
    • Shift Toward Value-Based Healthcare Models Strengthens Business Case for Cost-Efficient OBL Settings
    • Growing Preference Among Physicians for Greater Procedural Autonomy Throws the Spotlight on In-Office Procedure Suites
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Office-based Labs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Office-based Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single Specialty Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Multi-Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Multi-Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Multi-Specialty Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hybrid Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hybrid Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hybrid Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Peripheral Vascular Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Peripheral Vascular Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Interventional Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Endovascular Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Endovascular Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • JAPAN
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • CHINA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • EUROPE
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Office-based Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • FRANCE
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • GERMANY
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Office-based Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • INDIA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Office-based Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Office-based Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • AFRICA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030

IV. COMPETITION